相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
Dilip Nathwani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
Christina M. Surawicz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
Oliver A. Cornely et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sustained Clinical Response as an Endpoint in Treatment Trials of Clostridium difficile-Associated Diarrhea
Stuart Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Derrick W. Crook et al.
CLINICAL INFECTIOUS DISEASES (2012)
Current Status of Clostridium difficile Infection Epidemiology
Fernanda C. Lessa et al.
CLINICAL INFECTIOUS DISEASES (2012)
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
P. N. Wiegand et al.
JOURNAL OF HOSPITAL INFECTION (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Clostridium difficile Infection: New Insights Into Management
Sahil Khanna et al.
MAYO CLINIC PROCEEDINGS (2012)
Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile
Farah Babakhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Metronidazole-Induced Central Nervous System Toxicity: A Systematic Review
Akira Kuriyama et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Clostridium difficile Colitis: Factors Associated with Outcome and Assessment of Mortality at a National Level
David B. Stewart et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clostridium difficile Infection
Latisha Heinlen et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile
Ellie J. C. Goldstein et al.
ANAEROBE (2010)
First Report of Hypervirulent Strains Polymerase Chain Reaction Ribotypes 027 and 078 Causing Severe Clostridium difficile Infection in Italy
Rossella Baldan et al.
CLINICAL INFECTIOUS DISEASES (2010)
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients
T. Parks et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland
K. Burns et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Indirect Comparisons: A Review of Reporting and Methodological Quality
Sarah Donegan et al.
PLOS ONE (2010)
Prevention and medical management of Clostridium difficile infection
J. Shannon-Lowe et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain
Jennifer R. O'Connor et al.
GASTROENTEROLOGY (2009)
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials
S. J. Edwards et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Stuart Johnson
JOURNAL OF INFECTION (2009)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses
Y. K. Shue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
Wafa N. Al-Nassir et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078
Abraham Goorhuis et al.
CLINICAL INFECTIOUS DISEASES (2008)
Rising economic impact of Clostridium difficile - Associated disease in adult hospitalized patient population
Xiaoyan Song et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Direct versus indirect comparisons: A summary of the evidence
Gerald Gartlehner et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Analysis of 30-day mortality for Clostridium difficile -: Associated disease in the ICU setting
Claire Kenneally et al.
CHEST (2007)
In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004
David W. Hecht et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Vancomycin-resistant enterococci: Colonization, infection, detection, and treatment
A Zirakzadeh et al.
MAYO CLINIC PROCEEDINGS (2006)
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
In vitro activities of OPT-80 and comparator drugs against intestinal bacteria
SA Finegold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species
KL Credito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activity of OPT-80 against clostridium difcile
G Ackermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses
F Song et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
L Kyne et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
